Literature DB >> 19531498

Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Nicolas Fissolo1, Sabrina Haag, Katrien L de Graaf, Oliver Drews, Stefan Stevanovic, Hans Georg Rammensee, Robert Weissert.   

Abstract

Tandem mass spectrometry was used to identify naturally processed peptides bound to major histocompatibility complex (MHC) I and MHC II molecules in central nervous system (CNS) of eight patients with multiple sclerosis (MS). MHC molecules were purified from autopsy CNS material by immunoaffinity chromatography with monoclonal antibody directed against HLA-A, -B, -C, and -DR. Subsequently peptides were separated by reversed-phase HPLC and analyzed by mass spectrometry. Database searches revealed 118 amino acid sequences from self-proteins eluted from MHC I molecules and 191 from MHC II molecules, corresponding to 174 identified source proteins. These sequences define previously known and potentially novel autoantigens in MS possibly involved in disease induction and antigen spreading. Taken together, we have initiated the characterization of the CNS-expressed MHC ligandome in CNS diseases and were able to demonstrate the presentation of naturally processed myelin basic protein peptides in the brain of MS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19531498      PMCID: PMC2742442          DOI: 10.1074/mcp.M900001-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  80 in total

1.  Probability-based protein identification by searching sequence databases using mass spectrometry data.

Authors:  D N Perkins; D J Pappin; D M Creasy; J S Cottrell
Journal:  Electrophoresis       Date:  1999-12       Impact factor: 3.535

2.  Allelic variations in rat MHC class II binding of myelin basic protein peptides correlate with encephalitogenicity.

Authors:  K L de Graaf; R Weissert; P Kjellén; R Holmdahl; T Olsson
Journal:  Int Immunol       Date:  1999-12       Impact factor: 4.823

3.  Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease.

Authors:  A Fogdell-Hahn; A Ligers; M Grønning; J Hillert; O Olerup
Journal:  Tissue Antigens       Date:  2000-02

4.  A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.

Authors:  L S Madsen; E C Andersson; L Jansson; M krogsgaard; C B Andersen; J Engberg; J L Strominger; A Svejgaard; J P Hjorth; R Holmdahl; K W Wucherpfennig; L Fugger
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

Review 5.  Type 1 diabetes as a relapsing-remitting disease?

Authors:  Matthias von Herrath; Srinath Sanda; Kevan Herold
Journal:  Nat Rev Immunol       Date:  2007-12       Impact factor: 53.106

6.  Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

Authors:  May H Han; Sun-Il Hwang; Dolly B Roy; Deborah H Lundgren; Jordan V Price; Shalina S Ousman; Guy Haskin Fernald; Bruce Gerlitz; William H Robinson; Sergio E Baranzini; Brian W Grinnell; Cedric S Raine; Raymond A Sobel; David K Han; Lawrence Steinman
Journal:  Nature       Date:  2008-02-17       Impact factor: 49.962

7.  Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC.

Authors:  Bartosz Bielecki; Andzelika Mazurek; Paweł Wolinski; Andrzej Glabinski
Journal:  J Clin Immunol       Date:  2007-10-25       Impact factor: 8.317

Review 8.  Adhesion molecules and kinases involved in gammadelta T cells migratory pathways: implications for viral and autoimmune diseases.

Authors:  Alessandro Poggi; Silvia Catellani; Daniela Fenoglio; Giovanna Borsellino; Luca Battistini; Maria Raffaella Zocchi
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

9.  Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.

Authors:  M Krogsgaard; K W Wucherpfennig; B Cannella; B E Hansen; A Svejgaard; J Pyrdol; H Ditzel; C Raine; J Engberg; L Fugger; B Canella
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

10.  Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis.

Authors:  K Rejdak; A Petzold; Z Stelmasiak; G Giovannoni
Journal:  Mult Scler       Date:  2007-09-24       Impact factor: 6.312

View more
  31 in total

1.  The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity.

Authors:  Cristina C Clement; Aniuska Becerra; Liusong Yin; Valerio Zolla; Liling Huang; Simone Merlin; Antonia Follenzi; Scott A Shaffer; Lawrence J Stern; Laura Santambrogio
Journal:  J Biol Chem       Date:  2016-01-06       Impact factor: 5.157

2.  Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation.

Authors:  Miguel Álvaro-Benito; Eliot Morrison; Friederike Ebner; Esam T Abualrous; Marie Urbicht; Marek Wieczorek; Christian Freund
Journal:  Cell Mol Immunol       Date:  2018-11-22       Impact factor: 11.530

3.  Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.

Authors:  Leonia Bozzacco; Haiqiang Yu; Henry A Zebroski; Jörn Dengjel; Haiteng Deng; Svetlana Mojsov; Ralph M Steinman
Journal:  J Proteome Res       Date:  2011-10-14       Impact factor: 4.466

4.  Deimination of the myelin basic protein decelerates its proteasome-mediated metabolism.

Authors:  E S Kuzina; A A Kudriaeva; I S Glagoleva; V D Knorre; A G Gabibov; A A Belogurov
Journal:  Dokl Biochem Biophys       Date:  2016-09-07       Impact factor: 0.788

5.  Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis.

Authors:  Robert J Seward; Elise E Drouin; Allen C Steere; Catherine E Costello
Journal:  Mol Cell Proteomics       Date:  2010-11-16       Impact factor: 5.911

6.  HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.

Authors:  Simon D van Haren; Eszter Herczenik; Anja ten Brinke; Koen Mertens; Jan Voorberg; Alexander B Meijer
Journal:  Mol Cell Proteomics       Date:  2011-04-05       Impact factor: 5.911

7.  Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples.

Authors:  Tina Heyder; Maxie Kohler; Nataliya K Tarasova; Sabrina Haag; Dorothea Rutishauser; Natalia V Rivera; Charlotta Sandin; Sohel Mia; Vivianne Malmström; Åsa M Wheelock; Jan Wahlström; Rikard Holmdahl; Anders Eklund; Roman A Zubarev; Johan Grunewald; A Jimmy Ytterberg
Journal:  Mol Cell Proteomics       Date:  2016-07-24       Impact factor: 5.911

8.  A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?

Authors:  Kerrie Vaughan; Bjoern Peters; Kevin C O'Connor; Roland Martin; Alessandro Sette
Journal:  J Neuroimmunol       Date:  2013-12-12       Impact factor: 3.478

9.  A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.

Authors:  Elise E Drouin; Robert J Seward; Klemen Strle; Gail McHugh; Kianoosh Katchar; Diana Londoño; Chunxiang Yao; Catherine E Costello; Allen C Steere
Journal:  Arthritis Rheum       Date:  2013-01

10.  Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells.

Authors:  Katsuhiro Sasaki; Angela Bean; Shivanee Shah; Elizabeth Schutten; Priya G Huseby; Bjorn Peters; Zu T Shen; Vijay Vanguri; Denny Liggitt; Eric S Huseby
Journal:  J Immunol       Date:  2014-03-03       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.